Kayne Anderson Rudnick Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.71K Buy
145
+79
+120% +$3.66K ﹤0.01% 741
2025
Q1
$4.03K Sell
66
-26,196
-100% -$1.6M ﹤0.01% 744
2024
Q4
$1.49M Sell
26,262
-1,574
-6% -$89K ﹤0.01% 365
2024
Q3
$1.44M Sell
27,836
-832
-3% -$43K ﹤0.01% 366
2024
Q2
$1.19M Sell
28,668
-33,946
-54% -$1.41M ﹤0.01% 380
2024
Q1
$3.4M Sell
62,614
-2,516
-4% -$136K 0.01% 311
2023
Q4
$3.34M Sell
65,130
-2,792
-4% -$143K 0.01% 312
2023
Q3
$3.94M Sell
67,922
-509
-0.7% -$29.5K 0.01% 303
2023
Q2
$4.38M Sell
68,431
-25,775
-27% -$1.65M 0.01% 304
2023
Q1
$6.53M Hold
94,206
0.02% 272
2022
Q4
$6.78M Sell
94,206
-3,958
-4% -$285K 0.02% 281
2022
Q3
$6.98M Buy
98,164
+97,737
+22,889% +$6.95M 0.02% 263
2022
Q2
$33K Sell
427
-101
-19% -$7.81K ﹤0.01% 489
2022
Q1
$39K Buy
528
+101
+24% +$7.46K ﹤0.01% 469
2021
Q4
$27K Hold
427
﹤0.01% 503
2021
Q3
$25K Hold
427
﹤0.01% 498
2021
Q2
$29K Hold
427
﹤0.01% 494
2021
Q1
$27K Hold
427
﹤0.01% 489
2020
Q4
$26K Hold
427
﹤0.01% 465
2020
Q3
$26K Buy
427
+302
+242% +$18.4K ﹤0.01% 438
2020
Q2
$7K Hold
125
﹤0.01% 446
2020
Q1
$7K Hold
125
﹤0.01% 444
2019
Q4
$8K Buy
+125
New +$8K ﹤0.01% 429
2017
Q2
Sell
-206,786
Closed -$11.2M 334
2017
Q1
$11.2M Sell
206,786
-226,248
-52% -$12.3M 0.12% 170
2016
Q4
$25.3M Sell
433,034
-42,169
-9% -$2.46M 0.3% 98
2016
Q3
$25.6M Buy
475,203
+137,917
+41% +$7.44M 0.32% 88
2016
Q2
$24.8M Sell
337,286
-3,847
-1% -$283K 0.37% 73
2016
Q1
$21.8M Buy
341,133
+110,131
+48% +$7.03M 0.35% 79
2015
Q4
$15.9M Sell
231,002
-3,228
-1% -$222K 0.26% 107
2015
Q3
$13.9M Sell
234,230
-4,111
-2% -$243K 0.24% 110
2015
Q2
$15.9M Sell
238,341
-3,480
-1% -$232K 0.25% 110
2015
Q1
$15.6M Buy
241,821
+116,077
+92% +$7.49M 0.24% 114
2014
Q4
$7.42M Buy
+125,744
New +$7.42M 0.12% 152